Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
about
Novel drugs that target the metabolic reprogramming in renal cell cancerChoosing the right cell line for renal cell cancer researchDEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.Systemic modeling myeloma-osteoclast interactions under normoxic/hypoxic condition using a novel computational approachAssociation of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126.Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels.
P2860
Q26740187-F6AB334E-F32B-4702-9BAB-EB9DF97FCD91Q28073283-2D8BBEE6-87D2-46D2-8C6D-F89F327AC432Q35233163-5534AA4A-095C-4A34-8981-F96AD764CBB3Q38734040-A985202E-F972-4123-B94E-E66BE0A155D3Q38843122-EFDD35EB-C34C-40D7-A7CC-1FC2B0703789Q41592643-B64930E2-D165-494B-AA3E-83C43D08E77CQ54046985-19160A70-A985-4180-9930-9AFEC3BF5100
P2860
Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pan-PI-3 kinase inhibitor SF11 ...... ivity in renal cell carcinoma.
@en
type
label
Pan-PI-3 kinase inhibitor SF11 ...... ivity in renal cell carcinoma.
@en
prefLabel
Pan-PI-3 kinase inhibitor SF11 ...... ivity in renal cell carcinoma.
@en
P2093
P2860
P1476
Pan-PI-3 kinase inhibitor SF11 ...... ivity in renal cell carcinoma.
@en
P2093
Alok R Singh
Donald L Durden
Shweta Joshi
P2860
P2888
P304
P356
10.1007/S00280-014-2639-X
P577
2015-01-13T00:00:00Z
P6179
1036651050